CURRICULUM VITAE. Suzane Silbert

Similar documents
Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil

Intrinsic, implied and default resistance

A snapshot of polymyxin use around the world South America

DOI: /

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

BJID 2001; 5 (February) 21

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

CONTAGIOUS COMMENTS Department of Epidemiology

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

The Challenges of Antimicrobial Resistance in Brazil

Antimicrobial Resistance Strains

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

DEPARTMENT OF MEDICAL MICROBIOLOGY

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Summary of the latest data on antibiotic resistance in the European Union

RCH antibiotic susceptibility data

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT

EARS Net Report, Quarter

Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

CONTAGIOUS COMMENTS Department of Epidemiology

Dalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

2 P. aeruginosa: Resistance and Molecular Typing BJI 2002; 6 (February) macrorestriction analysis by pulsed field gel electrophoresis, have been succe

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

ORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

Multi-Drug Resistant Organisms (MDRO)

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

RESISTANT PATHOGENS. John E. Mazuski, MD, PhD Professor of Surgery

Public Health Response to Emerging Resistance

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Tel: Fax:

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Major Article. Luciana Azevedo Callefi [1], Eduardo Alexandrino Servolo de Medeiros [1] and Guilherme Henrique Campos Furtado [1] INTRODUCTION METHODS

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Mechanism of antibiotic resistance

Antimicrobial Stewardship:

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)

Human health impacts of antibiotic use in animal agriculture

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

CAVICIDE1. Technical Bulletin

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE

Trends of 9,416 multidrug-resistant Gram-negative bacteria

Antimicrobial Susceptibility Testing: Advanced Course

Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India

What s next in the antibiotic pipeline?

Antimicrobial Resistance and Prescribing

Antimicrobial Cycling. Donald E Low University of Toronto

CONTAGIOUS COMMENTS Department of Epidemiology

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results

Testimony of the Natural Resources Defense Council on Senate Bill 785

Decrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in

Understanding the Hospital Antibiogram

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

New Drugs for Bad Bugs- Statewide Antibiogram

ANTIBIOTIC STEWARDSHIP

Resistance trends of Acinetobacter

Service Delivery and Safety Department World Health Organization, Headquarters

Occurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil

Management of Hospital-acquired Pneumonia

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Multi-drug resistant microorganisms

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

PrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Metallo Beta Lactamase Producing Pseudomonas aeruginosa in a Tertiary Care Hospital

Journal of Hospital Infection

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

CONTAGIOUS COMMENTS Department of Epidemiology

Transcription:

CURRICULUM VITAE Suzane Silbert, PhD 1. PERSONAL DATA Name: Suzane Silbert Sex: Female Date of Birth: October 27, 1968 Place of Birth: Porto Alegre, Brazil Marital Status: Married E-mail addresses: ssilbert@tgh.org Present Address: Esoteric Testing Laboratory Clinical Lab/Pathology Department Tampa General Hospital One Tampa General Circle Tampa, Florida 33606-3571 2. EDUCATION Biological Sciences: Pontifícia Universidade Católica do Rio Grande do Sul. Porto Alegre, RS, Brazil. From: 1986 to 1990. Master Degree: Thesis: Evaluation of the Antimicrobial Susceptibility and Molecular Typing of Pseudomonas aeruginosa isolated from CF patients. [Avaliação do Perfil de Sensibilidade a Antimicrobianos e Tipagem Molecular de Pseudomonas aeruginosa isoladas de pacientes portadores de Fibrose Cística]. Infectious and Parasitologic Diseases Program. Federal University of São Paulo. São Paulo, SP, Brazil. From: 1997 to 1999. Ph.D Degree: Thesis: Molecular Typing of Non-Fermentative Gram-Negative Bacilli: Applicability of Different Techniques. [Tipagem Molecular de Bacilos Gram-Negativos Não-Fermentadores: Comparação e Aplicabilidade de Diferentes Técnicas]. Infectious and Parasitologic Diseases Program. Federal University of São Paulo. São Paulo, SP, Brazil. From: 2000 to 2004. 3. PROFESSIONAL TITLES AND LICENSES: Certified as a Specialist in Microbiology and Molecular Biology: Conselho Regional de Biologia 1 Região (Brazilian Biology Board), 2005. Certified as a Medical Technologist: Board of Directors, American Medical Technologists, AMT, 2008. ID Number: 239644 Certified as a Clinical Laboratory Technologist in Microbiology: Florida Board of Clinical Laboratory Personnel Licensure, 2009. License Number: TN 42190 1

4.1. POSITIONS AND EMPLOYMENT Microbiologist of the Clinical Microbiology Laboratory Pathology Department - Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil. September 1991 to June 1997 Microbiologist of the Sexual Transmitted Diseases Laboratory Pregnant Women HIV Clinic - Federal University of São Paulo EPM São Paulo, SP, Brazil. October 1997 to March 1999 Supervisor of the Special Clinical Microbiology Laboratory Infectious Diseases Division - Federal University of Sao Paulo EPM São Paulo, SP, Brazil. June 2000 to March 2004 Lab Technical Coordinator Department of Clinical Pathology Albert Einstein Hospital (Certified by Joint Commission International) São Paulo, SP, Brazil. March 2004 to June 2007 Molecular Typing Lab Section Coordinator Infectious Diseases Division - Federal University of Sao Paulo EPM São Paulo, SP, Brazil. June 2000 to August 2007 Clinical Microbiologist Investigator Infectious Disease Section Bay Pines VA Healthcare System VHCS Bay Pines, FL. USA. November 2007 to May 2009 Clinical Scientist Esoteric Testing Laboratory - Clinical Lab/Pathology Department Tampa General Hospital. June 2009 to present 4.2. PROFESSIONAL TRAINING Genetic Department Federal University of Rio Grande do Sul Porto Alegre, RS, Brazil. August 1986 to July 1987 Clinical Microbiology Laboratory Clinical Pathology Department - Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil. April 1988 to May 1991 Micology Laboratory Dermatology Service - Santa Casa de Misericórdia do Rio de Janeiro Rio de Janeiro, RJ, Brazil. June to August 1991 Microbiology Laboratories Royal Brompton Hospital and Central Public Health Laboratory London, UK. October 1992 Laboratory of Hospital Infection Central Public Health Laboratory London, UK. March 1995 2

Molecular Epidemiology and Fungus Testing Lab Pathology Department - University of Iowa Hospitals and Clinics Iowa City, IA, USA. April 1999 to May 2000 5. PEER-REVIEWED PUBLICATIONS 5.1. Silbert, S, Rosa, D, Matte, U, Goldim, JR, Barcellos, S, Procianoy, R. Staphylococcus sp. coagulase negative from blood cultures of newborn patients: infection versus contamination. Jornal de Pediatria. May, 1997. 5.2. E. Sprinz, R.Mallman, S.Barcellos, S.Silbert, G.Schestatsky and Bem David. Aids-related cryptosporidial diarrhoea: an open study with roxithromycin. Journal of Antimicrobial Chemotherapy. 41, Suppl.B, 85-91.1998. 5.3. Roland, RK; Mendes, RE; Silbert, S; Bolsoni, AP. Sader, HS. In vitro Antimicrobial Activity of Piperacillin/Tazobactam in Comparison With Other Broad Spectrum ß-Lactams. The Brazilian Journal of Infectious Diseases. 4 (5): 226-235. 2000. 5.4. Silbert, S.; Barth AL; Sader, HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian Cystic Fibrosis Patients. Journal of Clinical Microbiology. 39 (11): 3976-3981. 2001. 5.5. Cereda, R.F.; Gales, AC; Silbert, S; Jones, RN; Sader, HS. Molecular Typing and Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium (VRE) in Brazil. Infection Control Hospital Epidemiology. 23(1): 19-22. 2002. 5.6. Sejas, LM; Silbert, S; Reis, AO; Sader, HS. Evaluation of the quality of the antimicrobial agents disks used in disk-diffusion tests commercially available in Brazil. Jornal Brasileiro de Patologia. 39 (1): 27-35, 2003. 5.7. Gales, AC; Menezes, LC; Silbert, S; Sader, HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamase. Journal of Antimicrobial Chemotherapy. 52: 699-702, 2003. 5.8. Silbert, S; Boyken, L; Hollis, RJ; Pfaller, MA. Improving Typeability of Multiple Bacterial Species Using Pulsed-Field Gel Electrophoresis and Thiourea. Diagnostic Microbiology and Infectious Diseases. 47 (4): 619-621, 2003. 5.9. Castanheira, M; Jones, RN; Silbert, S; Brandileone, MCC; Sader, HS. Typing and Molecular Characterization of Streptococcus pneumoniae with Reduced Susceptibility to Cefotaxime Isolated in Latin America. Microbial Drug Resistance Mechanisms Epidemiology and Disease. 9 (4): 345-351, 2003. 5.10. Tosin, I; Silbert, S; Sader, HS. The use of Molecular Typing to Evaluate the Dissemination of Antimicrobial Resistance among Gram-negative Rods in Brazilian Hospitals. The Brazilian Journal of Infectious Diseases. 7(6): 360-369, 2003. 5.11. Cordeiro, JCR; Silbert, S; Reis, AO; Sader, HS. Inter-Hospital Dissemination of Glycopeptide Resistant Enterococcus faecalis in Brazil. Clinical Microbiology and Infection. 10(3): 260-262, 2004. 5.12. Silbert, S.; Pfaller MA; Hollis RJ; Barth AL; Sader HS. Evaluation of Three Molecular Typing Techniques for Nonfermentative Gram-Negative Bacilli. Infection Control and Hospital Epidemiology. 25(10): 847-851, 2004. 5.13. Barbosa D; Lima L; Silbert, S.; Sader HS; Cendoroglo M; Draibe S; Camargo L; Vianna L; A. Belasco; Sesso R. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am Journal of Kidney Diseases. 44(2): 337-343, 2004. 3

5.14. Tognin MC; Andrade SS; Silbert, S.; Gales AC; Jones RN; Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. International Journal of Infectious Diseases.8: 284-291, 2004. 5.15. Sader HS; Reis AO; Silbert, S; Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-betalactamases in a Brazilian hospital. Clinical Microbiology and Infection. 11: 73-76, 2005. 5.16. Ribeiro J; Mendes RE; Domingos R; França E; Silbert, S; Jones RN; Sader HS. Microbiological and Epidemiological Characterization of Imipenem-Resistant Pseudomonas aeruginosa Strains from a Brazilian Tertiary Hospital: Report from the SENTRY Antimicrobial Surveillance Program. Journal of Chemotherapy.18: 461-467, 2006. 5.17. Freitas, MC; Pacheco-Silva, A; Barbosa D; Silbert, S; Sader HS; Sesso R; Camargo, LFA. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infectious Diseases (Online). 6: 133, 2006. 5.18. Tognin MC; Gales AC; Penteado A; Silbert, S; Sader HS. Dissemination of IMP-1 Metallo-Beta- Lactamase-Producing Acinetobacter spp. in a Brazilian Teaching Hospital. Infection Control and Hospital Epidemiology. 27 (7): 742-747, 2006. 5.19. Zavascki, A., Soares, F., Superti, S., Silbert, S., Silva, F. M., Barth AL. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa. International Journal of Antimicrobial Agents, 30: 187-189, 2007. 5.20. R. Sitnik, H. Sette Jr., R.A.F. Santana, L.C. Menezes, C.H.N. Graça, G.T.F. Dastoli, S. Silbert, J.R.R. Pinho. Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler. Brazilian Journal of Medical and Biological Research, 40 (12): 1689-92, 2007. 5.21. Almeida, M. T. G., Rubio, F. G., Garcia, D. O., Pavarino-Bertelli, E. C., Rossit, A. R. B., Bando, S. Y., Silbert, S., Goloni-Bertollo, E. M., Soares, M. M. C. N., Martinez, M. B. Genetic relatedness among clinical strains of Stenotrophomonas maltophilia in tertiary care hospital settings in Sao Paulo State, Brazil. Brazilian Journal of Microbiology,38: 278-284, 2007. 5.22. d'azevedo, P. A., Furtado, G., Medeiros EAS, Santiago, K. A., Silbert, S, Pignatari ACC. Molecular characterization of vancomycin-resistant Enterococci strain eight years apart from its first isolation in São Paulo, Brazil. Journal of the São Paulo Institute of Tropical Medicine [Revista do Instituto de Medicina Tropical de São Paulo], 50: 195-198, 2008. 5.23. Silva, F.M., Carmo, M.S., Silbert, S., Gales, A.C. SPM-1-Producing Pseudomonas aeruginosa: Analysis of the Ancestor Relationship Using Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Automated Ribotyping. Microbial Drug Resistance, 17 (2): 215-20, 2011. 5.24. Monteiro, J., Widen, R., Kubasek, C., Pignatari, A.C.C., Silbert, S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother, doi:10.1093/jac/dkr563. Jan, 2012. 6. BOOK CHAPTER 6.1. Sitnik, R; Silbert, S; Pinho, JRR. Viral Resistance: Genotyping, Phenotyping and Virtual Phenotyping. [Resistência Viral: Genotipagem, Fenotipagm e Fenotipagem Virtual]. In: Roberto Focaccia. (Org.) VERONESI - Tratado de Infectologia. 3 ed. São Paulo: Atheneu, 2005, 1: 242-263. 4

7. AD HOC REVIEWER 7.1. Diagnostic Microbiology and Infectious Diseases. Since: 2005. 7.2. Infection Control and Hospital Epidemiology. Since: 2007. 7.3. American Journal of Infection Control. Since: 2007. 7.4. Brazilian Journal of Microbiology. Since: 2011 7.5. Journal of Antimicrobial Chemotherapy. Since: 2012. 7.6. Journal of Medical Microbiology. Since: 2012. 7.7. Journal of Virological Methods. Since: 2012. 7.8. Journal of Cystic Fibrosis. Since: 2012. 7.9. Molecular Biology Reports. Since: 2012. 8. INVITED LECTURES, COURSES MINISTRATED AND CONFERENCES PRESENTATION Total: 40 9. POSTER PRESENTATIONS IN SCIENTIFIC MEETINGS Total: 75 10. SCIENTIFIC SOCIETY MEMBERSHIP American Society for Microbiology: Membership # 55402267 Since: 1998 11. PARTICIPATION IN MEETINGS, SYMPOSIUMS AND COURSES Sixty-three participations in meetings, symposiums and courses, most of them about Clinical Microbiology and Molecular Biology. Updated: Dec, 2012 5